CD274 and lung adenocarcinoma: We identified the percentage of PD-L1 expression in the BM, although these were only reported in three of the 72 included studies.17–19 We found a total of 28 patients, consisting of 21 lung adenocarcinoma (75%), 6 SCC (21.4%), and 1 with subtype data unavailable (3.6%).